OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression
Jen‐Tsung Yang, I‐Neng Lee, Cheng Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7703-7703
Open Access | Times Cited: 7
Jen‐Tsung Yang, I‐Neng Lee, Cheng Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7703-7703
Open Access | Times Cited: 7
Showing 7 citing articles:
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
Sooyeon Oh, Sang‐Soo Lee, Hoeyoung Jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Sooyeon Oh, Sang‐Soo Lee, Hoeyoung Jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
Mahsa Palizkaran Yazdi, Amirhosein Barjasteh, Meysam Moghbeli
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Mahsa Palizkaran Yazdi, Amirhosein Barjasteh, Meysam Moghbeli
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
MicroRNA biosensors for detection of glioblastoma
Mehdi Fattahi, Mohadese Maghsudlu, Masoumeh Razipour, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117829-117829
Closed Access | Times Cited: 4
Mehdi Fattahi, Mohadese Maghsudlu, Masoumeh Razipour, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117829-117829
Closed Access | Times Cited: 4
Protamine-Based Nanotherapeutics for Gene Delivery to Glioblastoma Cells
Sheila Barrios-Esteban, Sonia Reimóndez-Troitiño, Pablo Cabezas‐Sainz, et al.
Molecular Pharmaceutics (2025)
Closed Access
Sheila Barrios-Esteban, Sonia Reimóndez-Troitiño, Pablo Cabezas‐Sainz, et al.
Molecular Pharmaceutics (2025)
Closed Access
Liquid Biopsy in Pituitary Neuroendocrine Tumors—Potential Biomarkers for Diagnosis, Prognosis, and Therapy
Ligia Gabriela Tătăranu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4058-4058
Open Access
Ligia Gabriela Tătăranu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4058-4058
Open Access
Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the MET pathway in glioblastoma cells
Ming‐Shan Chen, Zhi-Yong Chong, Cheng Huang, et al.
Oncology Reports (2024) Vol. 51, Iss. 5
Open Access | Times Cited: 3
Ming‐Shan Chen, Zhi-Yong Chong, Cheng Huang, et al.
Oncology Reports (2024) Vol. 51, Iss. 5
Open Access | Times Cited: 3
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications
Fatemeh Hosseinpour-Soleimani, Zahra Salmasi, Younes Ghasemi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28167-e28167
Open Access | Times Cited: 2
Fatemeh Hosseinpour-Soleimani, Zahra Salmasi, Younes Ghasemi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28167-e28167
Open Access | Times Cited: 2
CircZNF609 and circNFIX as possible regulators of glioblastoma pathogenesis via miR-145-5p/EGFR axis
Elham Ghadami, Ali Gorji, Ahmad Pour‐Rashidi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Elham Ghadami, Ali Gorji, Ahmad Pour‐Rashidi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
